Compare TNC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNC | EVO |
|---|---|---|
| Founded | 1870 | 1993 |
| Country | United States | Germany |
| Employees | N/A | 4766 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 821.2M |
| IPO Year | 1994 | N/A |
| Metric | TNC | EVO |
|---|---|---|
| Price | $67.95 | $2.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $79.00 | $7.00 |
| AVG Volume (30 Days) | ★ 332.8K | 110.1K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.82% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.36 | N/A |
| Revenue | ★ $1,137,600,000.00 | N/A |
| Revenue This Year | $5.44 | N/A |
| Revenue Next Year | $5.28 | $7.13 |
| P/E Ratio | $28.91 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $60.18 | $2.31 |
| 52 Week High | $85.91 | $4.80 |
| Indicator | TNC | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 51.80 | 36.10 |
| Support Level | $60.18 | $2.31 |
| Resistance Level | $84.24 | $3.78 |
| Average True Range (ATR) | 1.87 | 0.08 |
| MACD | 1.13 | 0.01 |
| Stochastic Oscillator | 89.72 | 22.51 |
Tennant Co is engaged in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions. Its products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools, and more.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.